Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)
Tizanidine
Product Images NDC 53002-1418
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 53002-1418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)
Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)
Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)
The text describes an improvement in Ashworth Score, with dosages of around 26.8 mg. The data is presented in tables with different study weeks mentioned. The endpoint is also last observation carried forward.*
Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)
This text only contains the name of a company "UNICHEM PHARMACEUTICALS (USA). INC." and does not provide any further information.*
Label Image (Lbl530021418)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
